Literature DB >> 16481092

Techniques and long-term results of surgical procedures for BPH.

Oliver Reich1, Christian Gratzke, Christian G Stief.   

Abstract

OBJECTIVE: To provide an overview on the current status of the long-term outcomes of instrumental treatment options for patients with lower urinary tract symptoms that are suggestive of bladder outlet obstruction.
METHODS: Based on MEDLINE database searches, we performed a systematic review of the literature with a focus on peer-reviewed articles about surgical benign prostatic hyperplasia (BPH) therapy published between 2000 and 2005. Special emphasis was given to randomized controlled trials on long-term outcome with a minimum follow-up of five years.
RESULTS: Data on clinical outcome with a follow-up of more than 10 years are available for open prostatectomy (OP), transurethral resection of the prostate (TURP), and transurethral microwave therapy. Studies with a follow-up of at least five years are obtainable for transurethral incision of the prostate, transurethral vaporisation of the prostate, transurethral needle ablation of the prostate, Holmium:YAG laser enucleation of the prostate, potassium-titanyl-phosphate laser vaporization of the prostate, and interstitial laser coagulation of the prostate. Among these long-term reports, OP and TURP provide the most durable results.
CONCLUSIONS: The most substantial long-term data on surgical procedures for BPH are available for conventional therapy, namely TURP. Concerning the techniques that have emerged within the last decade, there is clear evidence that the outcomes are more sustainable for truly ablative and thus deobstructing procedures.

Entities:  

Mesh:

Year:  2006        PMID: 16481092     DOI: 10.1016/j.eururo.2005.12.072

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  65 in total

1.  Bipolar vaporization of the prostate: is it ready for the primetime?

Authors:  Viorel Bucuras; Razvan Bardan
Journal:  Ther Adv Urol       Date:  2011-12

2.  Monopolar vs. bipolar TURP: assessing their clinical advantages.

Authors:  Pierre-Alain Hueber; Ahmed Al-Asker; Kevin C Zorn
Journal:  Can Urol Assoc J       Date:  2011-12       Impact factor: 1.862

3.  Analysis of the learning curve for transurethral resection of the prostate. Is there any influence of musical instrument and video game skills on surgical performance?

Authors:  Kleiton Gabriel Ribeiro Yamaçake; Elcio Tadashi Nakano; Iva Barbosa Soares; Paulo Cordeiro; Miguel Srougi; Alberto Azoubel Antunes
Journal:  Turk J Urol       Date:  2015-09

4.  [S2e guideline of the German urologists: Instrumental treatment of benign prostatic hyperplasia].

Authors:  T Bschleipfer; T Bach; R Berges; K Dreikorn; C Gratzke; S Madersbacher; M-S Michel; R Muschter; M Oelke; O Reich; C Tschuschke; K Höfner
Journal:  Urologe A       Date:  2016-02       Impact factor: 0.639

Review 5.  [Laser vaporization of the prostate: all as it should be?].

Authors:  O Reich; M Seitz
Journal:  Urologe A       Date:  2008-04       Impact factor: 0.639

Review 6.  Benign prostatic hyperplasia. Part 2--management.

Authors:  Timothy J Wilt; James N'Dow
Journal:  BMJ       Date:  2008-01-26

Review 7.  [Surgical and instrumental management of benign prostatic hyperplasia].

Authors:  R Muschter; O Reich
Journal:  Urologe A       Date:  2008-02       Impact factor: 0.639

8.  BPH treatment: laser for everyone | Opinion: YES.

Authors:  Carlos A R Sacomani; Ricardo Vita Nunes
Journal:  Int Braz J Urol       Date:  2018 Mar-Apr       Impact factor: 1.541

Review 9.  Technical aspects of holmium laser enucleation of the prostate for benign prostatic hyperplasia.

Authors:  Myong Kim; Hahn-Ey Lee; Seung-June Oh
Journal:  Korean J Urol       Date:  2013-09-10

10.  Long-term results of thulium laser resection of the prostate: a prospective study at multiple centers.

Authors:  Feng Sun; Bangmin Han; Di Cui; Fujun Zhao; Xiaowen Sun; Jian Zhuo; Yifeng Jing; Haitao Liu; Shujie Xia; Yong Yang; Guangheng Luo; Fengfu Guo
Journal:  World J Urol       Date:  2014-12-09       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.